• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Poor oral health: Cause or risk factor for future cardiovascular diseases
In this issue of the International Journal of Cardiology, Matsui et al. investigated the association between daily toothbrushing behavior and future cardiovascular (CV) events, including CV-death, myocardial infarction (MI), hospitalization for heart failure (HF) and stroke, in 692 participants during a median follow-up of 28  months [1]. This prospective study showed that group of subjects with poor oral hygiene (who brushed their teeth
Source: International Journal of Cardiology - February 9, 2022 Category: Cardiology Authors: Srdjan Aleksandric Tags: Editorial Source Type: research

Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus
Background:The differential benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) in cardiovascular or renal outcomes have not been fully investigated.Methods: Patients with diabetes prescribed SGLT2i or GLP1RA were retrospectively identified. Patients treated with antihyperglycemic medications other than SGLT2i or GLP1RA were used as a control group. Primary outcomes were composite ischemic events (acute coronary syndrome, coronary revascularization, and stroke) and a composite of heart failure and renal events (hospitalization for heart failure, renal death,...
Source: International Journal of Cardiology - June 14, 2022 Category: Cardiology Authors: Chee Hae Kim, In-Chang Hwang, Hong-Mi Choi, Chang Ho Ahn, Yeonyee E. Yoon, Goo-Yeong Cho Source Type: research

Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction
Beta blockers (BB) reduce chronotropic response and exercise capacity in heart failure with preserved ejection fraction (HFpEF). To analyze the influence of BB on exercise performance and O 2 pulse increase as a surrogate for stroke volume in HFpEF.
Source: International Journal of Cardiology - October 8, 2022 Category: Cardiology Authors: Wernhart Simon, Papathanasiou Maria, Amir Abbas Mahabadi, Rassaf Tienush, Luedike Peter Source Type: research

The dilemma of thromboembolism prophylaxis in patient with acute heart failure
Despite advances in treatment, heart failure (HF) continues to be associated with high morbidity and mortality [1]. One of the reasons for this fact is the thrombogenicity seen in these patients through different mechanisms (Fig. 1) via Virchow's triad: blood stasis, endothelial dysfunction, and hypercoagulability; resulting in reported rates of up to 30% of venous thromboembolism (VTE), stroke, and sudden death among HF patients [2]. On the other hand, atrial fibrillation (AF) frequently coexists increasing the risk of thromboembolic events, and while the efficacy of anticoagulants in this last population has been proven ...
Source: International Journal of Cardiology - December 16, 2022 Category: Cardiology Authors: H. Amparo Taveras Tags: Editorial Source Type: research

The role of adrenomedullin in acute coronary syndrome
In the study published by IJC [1] 7 circulating biomarkers related to hemostasis and fibrinolytic pathways, endothelial function and vascular regulation were analyzed in a cohort of 1370 patients with acute coronary syndrome. Moreover, their association with outcome of re-admission due to myocardial infarction, ischemic stroke, heart failure or death were assessed. Interestingly, their predictive value for outcome in relation to renal function was also determined. Chronic kidney disease patients have a well-known increased cardiovascular risk and have worse outcome after an acute coronary syndrome.
Source: International Journal of Cardiology - February 6, 2023 Category: Cardiology Authors: Roberto G. Carbone, Francesco Puppo Tags: Editorial Source Type: research

Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with hypertrophic obstructive cardiomyopathy (HOCM), with an estimated prevalence of approximately 20% [1]. AF is associated with malignant outcomes in patients with HOCM, with an increased risk of embolic stroke, heart failure, severe functional impairment and mortality [2]. Furthermore, AF is poorly tolerated by patients with HOCM, with increased heart failure episodes, hemodynamic instability and impaired quality of life [3].
Source: International Journal of Cardiology - July 8, 2023 Category: Cardiology Authors: Alessandra Sala, Ottavio Alfieri Tags: Editorial Source Type: research

Pages: 1  2  3  4  5  6  7  8  9